ARTICLE | Clinical News
Concerta methylphenidate regulatory update
November 1, 2004 8:00 AM UTC
FDA approved an sNDA for Concerta once-daily, extended-release 72 mg methylphenidate tablets for its use in adolescents with attention deficit hyperactivity disorder (ADHD). Concerta also is available...